How many 8-K filings has Edesa Biotech, Inc. filed?

Edesa Biotech, Inc. (EDSA) has 10 8-K (Current Event Report) filings on record, spanning May 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Edesa Biotech, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Edesa Biotech, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Edesa Biotech, Inc. (EDSA) — 8-K Filings

All 8-K filings from Edesa Biotech, Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

Edesa Biotech Files 8-K on Financials — Dec 12, 2025 Risk: low
Edesa Biotech, Inc. filed an 8-K on December 12, 2025, reporting on its results of operations and financial condition. The filing also includes financial statem
Edesa Biotech Files 8-K — Oct 28, 2025 Risk: medium
Edesa Biotech, Inc. filed an 8-K on October 28, 2025, reporting an "Other Event." The filing does not contain specific details about the event itself, but it co
Edesa Biotech Enters Material Agreement, Incurs Financial Obligation — Sep 30, 2025 Risk: medium
Edesa Biotech, Inc. filed an 8-K on September 30, 2025, reporting the entry into a material definitive agreement and the creation of a direct financial obligati
Edesa Biotech Files 8-K: Corporate Updates — Sep 9, 2025 Risk: low
Edesa Biotech, Inc. filed an 8-K on September 9, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing indicates the company's prin
Edesa Biotech Files 8-K on Officer Changes and Shareholder Votes — May 28, 2025 Risk: low
Edesa Biotech, Inc. filed an 8-K on May 28, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain off
8-K Filing — Feb 13, 2025
Edesa Biotech Reports Material Agreements and Equity Sales — Oct 31, 2024 Risk: medium
Edesa Biotech, Inc. filed an 8-K on October 30, 2024, reporting several material events. These include entering into and terminating definitive agreements, crea
Edesa Biotech Terminates Material Agreement — Oct 4, 2024 Risk: medium
Edesa Biotech, Inc. announced on October 3, 2024, the termination of a material definitive agreement. The company also filed financial statements and exhibits a
Edesa Biotech Files 8-K — Jun 24, 2024 Risk: low
Edesa Biotech, Inc. filed an 8-K on June 24, 2024, reporting on several items including Regulation FD Disclosure, Other Events, and Financial Statements and Exh
Edesa Biotech Appoints New CMO, Elects Directors — May 30, 2024 Risk: medium
Edesa Biotech, Inc. announced on May 30, 2024, the appointment of Dr. Parimal Sadhu as Chief Medical Officer and the election of Dr. Michael R. Bristow and Dr.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX